SNRPGP10

Across TCGA pan-cancer cohorts, SNRPGP10 RNA differs between tumor and matched normal tissue in 16 of 18 cancer types tested, making tumor–normal expression one of SNRPGP10’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where SNRPGP10 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types SNRPGP10 is over-expressed in tumor, although a few such as KICH and PAAD show the opposite, repressed pattern.

COAD, STAD, and HNSC are the cancer types where SNRPGP10 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SNRPGP10 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Female	II,III,IV	+1.539	<.001	8	view →
STAD	Female	All	+1.392	<.001	8	view →
HNSC	Male	All	+0.711	<.001	8	view →
BLCA	Male	III,IV	+0.711	.001	7	view →
LUSC	Male	II,III,IV	+1.080	<.001	6	view →
LIHC	All	All	+0.330	<.001	6	view →
ESCA	All	All	+1.688	<.001	5	view →
READ	All	All	+1.351	<.001	5	view →
LUAD	Female	All	+0.635	<.001	5	view →
KIRP	All	All	+0.333	.012	4	view →
BRCA	Female	All	+0.299	<.001	4	view →
KICH	All	All	−0.450	.001	3	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 16 lineages.

SNRPGP10–COAD

Open the COAD breakdown →